Could Valeant Pharmaceuticals Be Overcooked Down Here? |
March 17, 2016 | March 2016 Bond Updates |
Even if earnings were cut by half from already lowered guidance , could VRX be cheap? |
View more at: http://www.forbes.com/sites/jaysomaney/2016/03/16/could-valeant-pharmaceuticals-be-overcooked-down-here/ |
Related News |